ask="10.85"
ask_size="400"
average_daily_volume="164623"
bid="7.05"
bid_size="500"
book_value="0.00"
change="+0.15"
change_from_200_day_moving_average="6.74"
change_from_50_day_moving_average="1.16"
change_from_52_week_high="-0.17"
change_From_52_week_low="4.17"
change_in_percent="+1.48%"
close="10.27"
dividend_pay_date="6/27/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.47"
ebitda="0.00"
eps_estimate_current_year="-3.65"
eps_estimate_next_quarter="-0.75"
eps_estimate_next_year="-2.10"
ex_dividend_date="6/28/2013"
float_shares="N/A"
high="10.44"
high_52_weeks="10.44"
last_trade_date="2/7/2017"
last_trade_price="10.27"
last_trade_size="509"
last_trade_time="4:00pm"
low="9.94"
low_52_weeks="6.10"
market_capitalization="N/A"
moving_average_200_day="3.53"
moving_average_50_day="9.11"
name="Novelion Therapeutics Inc. "
notes="N/A"
one_year_target_price="13.62"
open="10.00"
pe_ratio="N/A"
peg_ratio="0.14"
percent_change_from_200_day_moving_average="+191.08%"
percent_change_from_50_day_moving_average="+12.79%"
percent_change_from_52_week_high="-1.63%"
percent_change_from_52_week_low="+68.36%"
previous_close="10.12"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.00"
stock_exchange="NMS"
symbol="NVLN"
volume="93250"
weeks_range_52="6.10 - 10.44"
